Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Na+/K+-ATPase inhibitors revealed by Sigma-Tau

July 12, 1996

Torii and Hisamitsu disclose elastase inhibitors

July 12, 1996

Novel 5-lipoxygenase inhibitors described by Pfizer

July 12, 1996

NOS inhibitors from Merck & Co.

July 12, 1996

Potential CNS disorders treatment from Janssen

July 12, 1996

Biphenyl iodinated derivatives for X-ray diagnosis from Bracco

July 12, 1996

Aryloxypropanolamine beta3-adrenoceptor agnoists from Bristol-Myers Squibb

July 12, 1996

Cathepsin B and L inhibitors in Fujisawa's pipeline

July 12, 1996

Multidrug resistance modifiers from Vertex

July 12, 1996

Arizona Board of Regents reports antitumor pentapeptides

July 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...